Atazanavir
Back to searchMolecule Structure
Scientific Name
Atazanavir
Description of the Drug
Atazanavir is an antiviral protease inhibitor used in combination with other antiretrovirals for the treatment of HIV.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01072
http://www.drugbank.ca/drugs/DB01072
Brand Name(s)
Reyataz
Company Owner(s)
Cipla Ltd, Bristol Myers Squibb Co, Laurus Labs Ltd, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Amneal Eu Ltd, Teva Pharmaceuticals Usa, Zydus Pharmaceuticals Usa Inc, Bristol-Myers Squibb Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL41696 | ||
| PharmGKB | PA10251 | ||
| Human Metabolome Database | HMDB0015205 | ||
| DrugBank | DB01072 | ||
| PubChem: Thomson Pharma | 14766361 | 14790731 | |
| PubChem | 148192 | ||
| Nikkaji | J1.006.724C | ||
| PDBe | DR7 | ||
| BindingDB | 13934 | ||
| EPA CompTox Dashboard | DTXSID9048691 | ||
| DrugCentral | 254 | ||
| Brenda | 2379 | ||
| Guide to Pharmacology | 11138 | ||
| rxnorm | REYATAZ | ATAZANAVIR | ATAZANAVIR SULFATE |
| ChEBI | 37924 | ||
| ZINC | ZINC000003941496 |
